StockpollyBeta
Get App
Popularity #1,020
BBNX · NASDAQ · Medical - Devices

Beta Bionics (BBNX)

Builds the iLet automated insulin delivery system for type 1 diabetes.

$22.71
After-hours close−0.09 (−0.39%)
At close$22.80(+3.45%)

  1. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX

    GlobeNewsWire

  2. Beta Bionics (BBNX) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 3, 2026 Lead Plaintiff Deadline

    Newsfile Corp

  3. Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

    GlobeNewsWire

  4. ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

    Newsfile Corp

  5. Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

    GlobeNewsWire

  6. BBNX Deadline Alert: SueWallSt Reminds Beta Bionics, Inc. (BBNX) Investors of Securities Class Action Deadline on November 3, 2026

    GlobeNewsWire

  7. BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

    GlobeNewsWire

  8. BBNX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

    Newsfile Corp

  9. CLASS ACTION NOTICE: Berger Montague Advises Beta Bionics, Inc. (BBNX) Investors to Inquire About a Securities Fraud Class Action

    Newsfile Corp

  10. BBNX Class Action: Beta Bionics Investors are Notified of the Upcoming November 3 Deadline in Ongoing Securities Fraud Class Action over Medical Device Safety

    PRNewsWire

  11. ROSEN, REGARDED INVESTOR RIGHTS COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

    GlobeNewsWire

  12. ROSEN, NATIONAL TRIAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

    Newsfile Corp

  13. Beta Bionics (NASDAQ: BBNX) Faces Securities Class Action Amid iLet FDA Compliance -- HBSS

    GuruFocus

  14. Beta Bionics (NASDAQ: BBNX) Faces Securities Class Action Amid iLet FDA Compliance -- HBSS

    PRNewsWire

  15. Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Deadline on November 3, 2026

    GlobeNewsWire

  16. BBNX Loss Alert: Lose Money on Your Beta Bionics Investment? BFA Law Reminds Investors of the Ongoing Securities Fraud Class Action to Recover Losses

    GlobeNewsWire

  17. Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    GlobeNewsWire

  18. BBNX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

    Newsfile Corp

  19. Beta Bionics (NASDAQ:BBNX) Insider Sells $58,300.00 in Stock

    Defense World

  20. Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

    GuruFocus